GSK plc (GSK) Form 6-K — Nov 20, 2026
GSK plc transferred 22,000,000 ordinary shares held in treasury to JPMorgan Chase Bank, N.A., its ADR depositary, to procure issuance of 11,000,000 ADRs to the GlaxoSmithKline (US) Trust on 20 November 2026. The ADRs will be used to satisfy awards under GSK's Deferred Annual Bonus Plan, Performance Share Plan and Share Value Plan, with the trustee paying $47.82 per ADR ($23.91 per ordinary share) funded by a GlaxoSmithKline LLC contribution. After the transfer, GSK holds 248,881,064 treasury shares with 4,067,451,066 ordinary shares in issue excluding treasury, leaving treasury voting rights at 6.12%.
Key figures
- Adrs issued
- 11000000
- Price per adr usd
- 47.82
- Total voting rights
- 4067451066
- Treasury shares held after
- 248881064
- Treasury shares transferred
- 22000000
- Price per ordinary share usd
- 23.91
- Treasury voting rights percent
- 6.12
- Ordinary shares in issue ex treasury
- 4067451066
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.